MedWatch

Demant CEO on implant recall and sales halt: "This is very serious"

A serious setback for Demant’s surgical division Oticon Medical, as the company has had to recall numerous implant devices due to a performance issue, in addition to halting the sales of said device, says President and CEO at Demant Søren Nielsen, who has launched a thorough investigation to locate the root cause.

Photo: Kenneth Lysbjerg Koustrup/Jyllands-Posten/Ritzau Scanpix

Hearing aid manufacturer Demant prepares for another economic blow. In 2019, the company was hit by a hacking attack that laid its operations low for several weeks. Then, the company was sent to its knees when the market froze over because of the Covid-19 pandemic.

After a functional error was discovered in a product, Demant’s subsidiary Oticon Medical announced on Thursday that it is withdrawing almost 4,000 non-implanted devices of its Neuro Zti product type. Additionally, the sales of said device have been stopped. Faulty devices will be removed from the 28 patients who have already had the cochlear device implanted.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs